Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Cagrilintide for Sale > Cagrilintide cas1415456-99-3 loss weight diabetes
Cagrilintide  cas1415456-99-3 loss weight diabetes buy - large image1
Cagrilintide  cas1415456-99-3 loss weight diabetes buy - image1
Cagrilintide  cas1415456-99-3 loss weight diabetes buy - image2
Cagrilintide  cas1415456-99-3 loss weight diabetes buy - image3
Cagrilintide  cas1415456-99-3 loss weight diabetes buy - image4
Cagrilintide  cas1415456-99-3 loss weight diabetes buy - image5

Cagrilintide cas1415456-99-3 loss weight diabetes

51 Inquiries

Unit Price:

$1/G FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Packaging:

1G/BAG

Price valid (until):

2029-03-29

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

PEG,Semaglutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Name:Cagrilintide
    CAS:1415456-99-3

    Cagrilintide is a peptide hormone, mainly used to treat diabetes. It can lower blood sugar and control blood sugar levels.
    Cagrilintide has the following properties: - Appearance: white to almost white powder - Use: mainly used to treat type 2 diabetes.


                                             ------------------- Company Profile ------------------

    VITALGEN PHARMA CO., LIMITED. is devoted to researching, manufacturing and marketing medical raw materials. The company has established a multi-functional R&D center in Shenzhen Zhongcheng Biomedical Industrial Park, which has a group of innovativedrugs and generic drugs technicians and 60 foreign trade professionals.


    VITALGEN PHARMA CO., LIMITED has built 500 square meters of pilot laboratories, equipped with two sets of 50L glass reactor, four sets of 100L double reactor, six sets of 50L rotary evaporator and matching heating and cooling equipment, to complete the 10kg Pilot complex experiments in complex compounds, a steady cooperation of the amplification plant, from 100kg to the tonnage of the enlarged production.


     medicine has been highly recognized by many well-known enterprises in the industry and has become their main supplier with high-quality products, honest and pragmatic attitude and good customer service. Tianyuan Medicine is dedicated to provide customers both at home and abroad with advanced technology and reasonable price , Quality products and professional technical services.

    Shop Cagrilintide  cas1415456-99-3 loss weight diabetes-Detailed Image 1

    Shop Cagrilintide  cas1415456-99-3 loss weight diabetes-Detailed Image 2

    Shop Cagrilintide  cas1415456-99-3 loss weight diabetes-Detailed Image 3

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    PEG,Semaglutide

    Location:

    1003 SHINGIND BLDG 42-46 TAI LIN PAI RD KWAI CHUNG HONGKONG

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A

    Average lead Time:

    350

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2018

     VITALGEN PHARMA CO., LIMITED is an international leading high-tech enterprise focusing on large-scale biosynthesis of polypeptide drugs. We provide all-round products and services from drug research, clinical development to access to market for global biotechnology and pharmaceutical enterprises.

    We have professional and experienced engineers and scientists, providing new polypeptide drug biosynthesis solutions, which help partners stay ahead of the polypeptide drug discovery, clinical development and market production.
    We have more than 5000 square meters of R&D center and 20000 square meters of intelligent manufacturing base, which can meet the needs of different customers and products, while meeting the GMP conditions for drug production

  • Inquiry History
    51 Inquiries
    Country Product Purchase Quantity Date Posted
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    United States

    Cagrilintide

    1 G May 18, 2026
    United States

    Cagrilintide

    20 MG May 8, 2026
    India

    Cagrilintide

    1 KG Apr 13, 2026
    United States

    Tirzepatide

    50 MT Apr 2, 2026
    India

    CAGRILINTIDE

    100 MG Mar 11, 2026
    United States

    Cagrilintide

    500 MG Feb 16, 2026
    Ghana

    carigrilintide

    10 MG Feb 9, 2026
    United States

    Cagrilintide

    20 MG Jan 13, 2026
    United States

    Cagrilintide

    1 KG Dec 15, 2025
    United States

    Cagrilintide

    1 KG Oct 11, 2025
    United States

    Cagrilintide

    25 MT Aug 13, 2025
    Germany

    Cagrilintide

    50 G Aug 3, 2025
    United States

    Cagrilintide

    10 MG Jul 3, 2025
    United States

    Cagrilintide

    1 G Jun 16, 2025
    United States

    Cagrilintide

    1 KG Apr 6, 2025
    United States

    Cagriliniitde

    Jan 24, 2025
    United States

    Cagrilintide

    100  Nov 7, 2024
    United States

    Cagrilintide

    100 MG Oct 5, 2024
    Thailand

    Carglitide

    10 MG Sep 9, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.